ICAP

A Randomized Non-Inferiority Study

A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults Living with HIV in Eswatini


Status

Coming

Locations

Our Approach

Research

Health Challenges

HIV, HPV